Private RSV Vaccination in London
RSV is a common winter virus that sends thousands of older adults — and people with heart, lung, kidney or weakened‑immune conditions — to hospital every year. If you're not covered by the NHS, you can be protected privately at our Hampstead clinic with Abrysvo, the same RSV vaccine the NHS uses. One appointment. £240, all‑inclusive.
Senior specialist pharmacist · 35 South End Road, Hampstead NW3 · Live online booking, no phone calls
Not eligible on the NHS? You can still protect yourself.
The NHS offers free RSV vaccination only to people aged 75 and over, care‑home residents, and pregnant women — based on what's most cost‑effective across the whole population, not on who benefits. Many at‑risk adults under 75 can still choose to be protected privately.
You can be vaccinated privately with us if you are:
- An adult aged 60–74 — the RSV vaccine is licensed for everyone 60+, but the NHS doesn't fund it below 75
- An adult aged 18–59 with a health condition that raises your risk — including chronic lung disease (COPD, asthma, bronchiectasis), heart disease, diabetes, kidney or liver disease, or a weakened immune system
- Someone who was vaccinated against RSV a few years ago and wants to top up protection — the NHS funds one dose only
- A private patient who simply wants protection ahead of the winter season
Who can have the RSV vaccination — free vs private
Understand your RSV risk
What is RSV?
Respiratory syncytial virus (RSV) is a common, very contagious virus that infects the nose, throat and lungs.
In healthy adults it usually feels like a heavy cold. But in older adults and people with underlying conditions, RSV can move into the lower airways and cause serious illness such as pneumonia, and can trigger flare‑ups of COPD, asthma and heart failure. RSV circulates mainly in autumn and winter in the UK, peaking around November and December.
Who is at higher risk?
Risk rises with age and with long‑term health conditions — and the two together multiply the danger.
- Aged 60 or over (especially 75+)
- Chronic lung disease — COPD, bronchiectasis, ILD, poorly controlled asthma
- Chronic heart disease, including heart failure
- A weakened immune system — blood cancer, transplant, chemotherapy or biologics
- Diabetes, chronic kidney or liver disease
- Living with frailty
What could happen?
For higher‑risk adults, RSV is not “just a cold” — it's a recognised cause of hospital admission.
RSV can cause pneumonia, low oxygen levels needing hospital treatment, and dangerous flare‑ups of existing heart and lung conditions. Older adults and those with chronic illness are most likely to need hospital care. Vaccination is the most effective way to reduce that risk.
About the RSV vaccine we use
We vaccinate with Abrysvo (Pfizer) — the same RSV vaccine the NHS uses for its older‑adult and pregnancy programmes.
What it is
A protein‑based (non‑live) RSV vaccine given as a single injection into the upper arm. Licensed in the UK for adults aged 60+ and adults 18–59 at increased risk of RSV lower‑respiratory disease.
How well it works
In UK real‑world use, it has been shown to cut the risk of being admitted to hospital with RSV by around 82% in older adults — with strong protection in higher‑risk groups including chronic lung disease, heart disease and weakened immunity.
What to expect
A short appointment and a single jab. Common side effects are usually mild and short‑lived — a sore arm, tiredness, headache or aching muscles for a day or two. Serious reactions are rare. Rarely, a small increased risk of Guillain-Barré syndrome (a nerve condition) has been seen in older adults after RSV vaccination; the benefits clearly outweigh it. Your pharmacist checks suitability and talks this through with you first.
How long does protection last?
Current evidence shows strong protection for at least two RSV seasons, after which it gradually fades. A single dose is expected to offer good protection for a few years.
In clinical trials, protection against more severe RSV disease was around 89% in the first season and about 78% in the second season, declining after that. The best timing for any repeat (booster) dose is still being studied.
Why this matters for you: the NHS funds one dose only. If you were vaccinated against RSV two or more seasons ago and you remain at higher risk, you may wish to discuss whether a further private dose is right for you — our pharmacist is happy to talk it through.
When to get vaccinated
RSV spreads mainly in autumn and winter, so late summer to early autumn is the ideal time — but the vaccine is available all year round.
An established private immunisation clinic — trusted since 2014
Your RSV vaccination is given by Mahyar Saremi, our senior specialist pharmacist (Superintendent Pharmacist & Independent Prescriber) — at a long‑established North London clinic rated 4.8/5 across 400+ Google reviews. A reliable, straightforward service from start to finish.
Your appointment includes
- A private suitability check with our senior specialist pharmacist
- The Abrysvo RSV vaccine
- Administration and a short observation period
- Aftercare advice and a vaccination record
Why patients choose us
- Senior specialist pharmacist — Mahyar Saremi, Superintendent Pharmacist & Independent Prescriber (GPhC 2069409)
- Established since 2014 — a trusted, independent North London immunisation clinic
- Convenient Hampstead location — 35 South End Road, NW3 2PY
- Live online booking — instant confirmation, no phone calls, same‑day slots often available
- Records sent to you and your GP after every appointment
- Can often be given alongside your flu or COVID‑19 vaccine — your pharmacist will advise
Book your RSV vaccination in 3 simple steps
Book online
Choose your appointment and pay a £25 deposit to reserve it.
Quick suitability check
Your pharmacist confirms the vaccine is right for you.
Get vaccinated
A single injection, plus aftercare advice. You're done.
The deposit you pay reserves your appointment and is deducted in full from the total service cost when you visit us, provided you meet our cancellation policy. See our full cancellation and refunds policy →
Secure booking by Semble · ISO 27001 & GDPR compliant
Covers your consultation with our specialist pharmacist, the Abrysvo vaccine, administration and aftercare — with your vaccination record sent to you and your GP. No hidden fees. The £25 deposit you pay at booking is deducted in full from this price.
Book your appointment →RSV vaccination — frequently asked questions
Who can have the RSV vaccine privately?
Any adult who wants protection and isn't covered by the free NHS programme — in particular adults aged 60–74, and adults aged 18–59 with a condition that raises their RSV risk (such as heart, lung, kidney or liver disease, diabetes, or a weakened immune system). Your pharmacist will confirm you're suitable.
I'm under 75 with a lung, heart or immune condition — am I eligible?
Yes. The RSV vaccine is licensed for adults aged 18–59 at increased risk and for all adults aged 60+. The NHS doesn't fund vaccination below 75 — but you can have it privately with us. In fact, the UK's vaccine advisers (the JCVI) have found that adults aged 65–74 with immunosuppression or chronic respiratory disease can benefit at least as much as the over‑75s.
Is this the same vaccine as the NHS gives?
Yes — we use Abrysvo (Pfizer), the same RSV vaccine used in the NHS older‑adult and pregnancy programmes.
I'm eligible for the NHS vaccine but can't get an appointment in time — can you help?
Yes. We don't provide the free NHS vaccine, but if you're eligible and can't access an NHS appointment quickly enough, you're welcome to be vaccinated privately with us. This matters most in pregnancy: the RSV vaccine is given from 28 weeks and ideally at least a couple of weeks before your baby is due, so there's time for protection to pass to your baby. This applies to only a small number of people.
How much does it cost? Are there any hidden fees?
£240, all‑inclusive — covering the consultation, the vaccine, administration and aftercare. The deposit you pay when booking comes off that total; there's nothing else to pay.
How effective is the RSV vaccine?
Very effective. In UK real‑world use it reduced the risk of hospital admission with RSV by around 82% in older adults, with strong protection in people with chronic lung disease, heart disease and weakened immunity.
How long does protection last? Will I need a booster?
Current evidence shows strong protection for at least two RSV seasons, then a gradual decline — a single dose is expected to give good protection for a few years. The ideal timing for any repeat dose is still being studied, so it's best discussed individually.
I had the RSV vaccine a few years ago — can I have another?
Possibly. The NHS funds only one dose, so if your protection has faded and you remain at higher risk, you can choose a further private dose. Our pharmacist will help you decide whether and when it's worthwhile.
Is the RSV vaccine safe? What are the side effects?
The most common side effects are mild and short‑lived — a sore arm, tiredness, headache or muscle aches for a day or two. Serious reactions are rare. A small increased risk of Guillain-Barré syndrome (a rare nerve condition) has been seen in older adults in the weeks after RSV vaccination — UK estimates suggest roughly 10 to 25 extra cases per million doses, and the Commission on Human Medicines has concluded the benefits of vaccination clearly outweigh this risk. Please read the Patient Information Leaflet, and your pharmacist will discuss this and any other precautions with you.
Can I have it at the same time as my flu or COVID vaccine?
Often yes — Abrysvo can be given at the same time as a seasonal flu or COVID‑19 vaccine. It's best confirmed at your appointment, so let us know which other vaccines you've had or are due.
When is the best time to get vaccinated?
RSV circulates mainly in autumn and winter, so late summer to early autumn is ideal — but the vaccine is available year‑round.
Do I need a referral or a prescription?
No. Our pharmacist assesses your suitability at the appointment — no GP referral or prescription needed. (Consultants are welcome to refer patients — see below.)
Where are you and how do I get there?
We're at 35 South End Road, Hampstead, London NW3 2PY . We're a short walk from Hampstead Heath Overground station and about 10–12 minutes from Belsize Park (Northern line), with several bus routes serving South End Green. On-street parking nearby is limited and pay-and-display, so public transport is usually easiest.
Can you vaccinate me at home?
Yes. We offer home vaccinations across our local area, with a minimum call‑out fee of £100 plus the cost of the vaccine. This can be ideal if you're housebound or would prefer not to travel. Email your postcode to info@hhpharmacy.co.uk for a quote.
Information for healthcare professionals & referring consultants
We welcome referrals from consultants whose patients fall outside the NHS RSV programme but remain at high risk of severe disease. We offer a straightforward private pathway with Abrysvo — the same vaccine the NHS uses — with consultation and vaccination by Mahyar Saremi, Superintendent Pharmacist and Independent Prescriber.
The gap in NHS provision
NHS funding covers adults aged 75 and over (extended to the over‑80s and all adult care‑home residents from April 2026) and pregnant women — set by population‑level cost‑effectiveness, not individual benefit. The JCVI's own analysis found adults aged 65–74 with immunosuppression or chronic respiratory disease gain at least as much as the over‑75s, and in 2026 it advised extending the programme to them — but provision below 75 is not yet commissioned. Adults aged 60–74, and 18–59 at increased risk, therefore remain unprotected unless they come privately.
What major guidelines recommend
Internationally, public‑health and specialist‑society guidance increasingly supports RSV vaccination well below 75 — particularly for chronic lung disease and immunosuppression:
| Guidance body | Year | Recommended groups |
|---|---|---|
| CDC / ACIPUSA — public health | 2024–25 (updated Apr 2025) | ≥ 75 yrs: routine. 50–74 yrs: if at increased risk. |
| STIKOGermany — public health | 2024–25 | ≥ 75 yrs: standard. 60–74 yrs: if severe comorbidity or care‑home resident. |
| IDSAUSA — infectious‑disease specialists | 2025–26 (Nov 2025) | All immunocompromised adults ≥ 18 yrs. Under 18: shared decision‑making. |
| GOLDInternational COPD society | 2026 | Per local/CDC guidance — GOLD 2026 advises RSV vaccination from age ≥ 50, or with chronic heart/lung disease. |
| GINAInternational asthma society | 2025–26 | Adults with asthma: follow local immunisation schedule, which includes RSV. |
Sources: CDC/ACIP (MMWR 2024 & Apr 2025 update); STIKO (from Aug 2024); IDSA (Nov 2025); GOLD 2026 report; GINA 2025. Shown for clinical context; UK provision follows JCVI/NHS commissioning.
1 · Chronic respiratory disease
COPD, bronchiectasis, ILD and severe/poorly‑controlled asthma — RSV is a recognised trigger of exacerbations. GOLD recommends RSV vaccination in COPD from age ≥ 60 (or with cardiopulmonary comorbidity).
Engage: respiratory medicine.
2 · Immunosuppression
Haematological malignancy, solid‑organ or stem‑cell transplant, biologic/immunosuppressive therapy, advanced CKD — the highest RSV‑associated mortality among 65–74s in the JCVI analysis.
Engage: haematology, oncology, transplant, renal, immunology/rheumatology.
3 · Chronic heart disease & frailty
Especially patients recently admitted with a cardiorespiratory exacerbation. A vaccination conversation at or after discharge is high‑yield.
Engage: cardiology (heart failure), care of the elderly, acute medicine.
Real‑world effectiveness — UK data (Abrysvo)
From a 2025 UKHSA study published in The Lancet Infectious Diseases (HARISS hospital surveillance, England), adults aged 75–79, 2024–25 season. Vaccine effectiveness against RSV‑associated hospital admission:
Vaccine, schedule & duration
Abrysvo (bivalent RSVpreF), a single intramuscular dose — the same vaccine used in the NHS programme. Trial efficacy against more severe RSV disease was ~89% (season 1) and ~78% (season 2), waning thereafter. As the NHS funds a single dose only, patients who remain at high risk may consider private revaccination as protection fades; the optimal interval is still under study. Full prescribing and safety information is in the Abrysvo Summary of Product Characteristics (SmPC).
How referral works
We take bookings online only (with a £25 deposit at the time of booking), so the simplest pathway is patient self‑booking:
- Advise your patient about our service and point them to hhpharmacy.co.uk/private-rsv-vaccine-london to book.
- They book in their own name — instant confirmation, no phone calls, same‑day slots often available.
- We assess suitability and vaccinate with Abrysvo.
- We send a full vaccination record to your patient and their GP — and to you, the referring consultant, on request.
For complex cases or to request a record, email info@hhpharmacy.co.uk.
References: Abrysvo SmPC (emc); UKHSA / Lancet Infectious Diseases HARISS effectiveness study (2025); JCVI RSV advice (2025–2026, GOV.UK); RSV Green Book chapter (GOV.UK); GOLD 2025 Report.
Protect yourself this RSV season
One appointment, one injection, lasting peace of mind. £240, all‑inclusive, at our Hampstead clinic.
Visit us
Hampstead Heath Pharmacy
35 South End Road, Hampstead, London NW3 2PY
Opening hours
Monday–Friday 09:00–18:30 · Saturday 09:00–17:30
General enquiries: 020 7435 7075 · info@hhpharmacy.co.uk
Appointments are booked online — we can't take bookings by phone.
Medically reviewed
Reviewed by Mahyar Saremi, Superintendent Pharmacist & Independent Prescriber (GPhC 2069409).
Last reviewed: May 2026 · Next review due: May 2027.
Regulated by the General Pharmaceutical Council · Premises No. 1040582. Hampstead Heath Pharmacy, registered in England & Wales (Company No. 01582798).
Abrysvo is a prescription‑only medicine. This page provides information about a private vaccination service and is not a substitute for individual medical advice; your suitability will be assessed by our pharmacist. Always read the Patient Information Leaflet (or the SmPC). If you experience a side effect, you can report it through the Yellow Card scheme at yellowcard.mhra.gov.uk. This is a private service and is not provided under the NHS.